• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Determination of plasma prothrombin levels by a novel Ca2+-dependent prothrombin activator (CA-1) in patients with chronic liver diseases.

作者信息

Nomura Fumio, Shimizu Shirou, Ohyama Masayuki, Sunaga Masahiko, Yokosuka Osamu, Ebara Masaaki, Saisho Hiromitsu

机构信息

Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba City, Chiba 260-8670, Japan.

出版信息

Clin Chim Acta. 2004 Mar;341(1-2):123-6. doi: 10.1016/j.cccn.2003.11.012.

DOI:10.1016/j.cccn.2003.11.012
PMID:14967167
Abstract
摘要

相似文献

1
Determination of plasma prothrombin levels by a novel Ca2+-dependent prothrombin activator (CA-1) in patients with chronic liver diseases.用一种新型钙离子依赖凝血酶原激活剂（CA-1）测定慢性肝病患者的血浆凝血酶原水平。
Clin Chim Acta. 2004 Mar;341(1-2):123-6. doi: 10.1016/j.cccn.2003.11.012.
2
Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.去γ-羧基凝血酶原对肝细胞癌患者的诊断敏感性和特异性因肿瘤大小而异。
Am J Gastroenterol. 2006 Sep;101(9):2038-43. doi: 10.1111/j.1572-0241.2006.00681.x. Epub 2006 Jul 18.
3
Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphisms.
Dig Liver Dis. 2005 Jun;37(6):446-50. doi: 10.1016/j.dld.2005.01.007. Epub 2005 Mar 16.
4
[The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].慢性乙型肝炎后不同阶段肝硬化患者血浆中尿激酶型纤溶酶原激活物、尿激酶型纤溶酶原激活物受体及纤溶酶原激活物抑制剂-1的水平
Zhonghua Gan Zang Bing Za Zhi. 2004 Feb;12(2):82-4.
5
[A discussion of standardization for prothrombin time in patients with advanced liver diseases].[晚期肝病患者凝血酶原时间标准化的探讨]
Zhonghua Gan Zang Bing Za Zhi. 2005 Feb;13(2):128-31.
6
[A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].[慢性肝病患者血清中肝纤维化标志物水平与肝组织纤维化阶段关系的定量研究]
Zhonghua Gan Zang Bing Za Zhi. 2005 Dec;13(12):911-4.
7
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.慢性肝炎、肝硬化和肝细胞癌患者的去γ-羧基凝血酶原、甲胎蛋白和甲胎蛋白-L3
J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.
8
Circulating vascular endothelial growth factor levels are decreased in patients with chronic hepatitis and liver cirrhosis depending on the degree of hepatic damage.根据肝损伤程度，慢性肝炎和肝硬化患者循环血管内皮生长因子水平降低。
Clin Sci (Lond). 2000 Aug;99(2):159-60.
9
Chromogranin A levels in chronic liver disease and hepatocellular carcinoma.慢性肝病和肝细胞癌中嗜铬粒蛋白A水平
Dig Liver Dis. 2009 Jan;41(1):31-5. doi: 10.1016/j.dld.2008.05.002. Epub 2008 Aug 30.
10
[Blood content of testosterone, progesterone and aldosterone in patients with chronic hepatitis and liver cirrhosis].[慢性肝炎和肝硬化患者睾酮、孕酮及醛固酮的血液含量]
Vrach Delo. 1984 Sep(9):36-8.